Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Nabeurs 21:58:33 | |||
| 123,20 EUR | -1,28% |
|
123,80 | +0,49% |
| 11/04 | REDCARE PHARMACY : Deutsche Bank bevestigt koopadvies | ZD |
| 09/04 | Europese aandelen kelderen nu de wederzijdse tarieven van Trump van kracht worden | RE |
Voorlopige winst- en verliesrekening: Redcare Pharmacy NV
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 968,1 | 1.060 | 1.204 | 1.799 | 2.371 | 2.993 | 3.630 | 4.334 |
| Variatie | - | 9,5% | 13,62% | 49,35% | 31,79% | 26,25% | 21,29% | 19,4% |
| EBITDA 1 | 21,62 | -5 | -8,044 | 53,5 | 33,3 | 63,3 | 119,3 | 168,1 |
| Variatie | - | -123,13% | -60,88% | 765,03% | -37,74% | 90,07% | 88,44% | 40,94% |
| Bedrijfsresultaat (EBIT) 1 | 5,556 | -32,3 | -47,55 | -3,793 | -34,91 | -18,4 | 11,5 | 58 |
| Variatie | - | -681,35% | -47,23% | 92,02% | -820,43% | 47,3% | 162,5% | 404,35% |
| Betaalde rente 1 | -15,11 | -11,76 | -15,29 | -15,5 | -16,68 | -8,44 | -7,8 | -6,225 |
| Resultaat voor belastingen (EBT) 1 | -15,93 | -77,88 | -84,12 | -14,35 | -47,83 | -22,09 | 47,2 | 90,55 |
| Variatie | - | -388,85% | -8,01% | 82,94% | -233,38% | 53,82% | 313,66% | 91,84% |
| Nettowinst (verlies) 1 | -16,77 | -74,2 | -77,65 | -12,04 | -45,46 | -22,18 | 32,09 | 70,42 |
| Variatie | - | -342,43% | -4,64% | 84,49% | -277,58% | 51,2% | 244,67% | 119,43% |
| Datum van publicatie | 3/03/21 | 2/03/22 | 7/03/23 | 5/03/24 | 11/03/25 | - | - | - |
1EUR in Miljoen
Geschatte gegevens
Balansprognose: Redcare Pharmacy NV
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuld 1 | -90 | -11 | 188 | 161 | 150 | 163 | 155 | 147 |
| Variatie | - | 87,78% | 1.809,09% | -14,36% | -6,83% | 8,32% | -4,91% | -5,16% |
| Datum van publicatie | 3/03/21 | 2/03/22 | 7/03/23 | 5/03/24 | 11/03/25 | - | - | - |
1EUR in Miljoen
Geschatte gegevens
Verwachte kasstroom: Redcare Pharmacy NV
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| CAPEX 1 | 53,34 | 43,16 | 53,52 | 38,22 | 42,15 | 60,32 | 72,22 | 79,99 |
| Variatie | - | -19,08% | 24,02% | -28,59% | 10,28% | 43,11% | 19,72% | 10,77% |
| Vrije kasstroom (FCF) 1 | -35,53 | -31,52 | -82,64 | 23,24 | -20,02 | -26,85 | 28,03 | 65,57 |
| Variatie | - | 11,28% | -162,14% | 128,12% | -186,18% | -34,08% | 204,41% | 133,89% |
| Datum van publicatie | 3/03/21 | 2/03/22 | 7/03/23 | 5/03/24 | 11/03/25 | - | - | - |
1EUR in Miljoen
Geschatte gegevens
Verwachte financiële ratio's: Redcare Pharmacy NV
| Fiscaal tijdperk: december | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
Winstgevendheid | ||||||||
| EBITDA-marge (%) | 2,23% | -0,47% | -0,67% | 2,97% | 1,4% | 2,12% | 3,29% | 3,88% |
| EBIT-marge (%) | 0,57% | -3,05% | -3,95% | -0,21% | -1,47% | -0,61% | 0,32% | 1,34% |
| EBT-marge (%) | -1,65% | -7,35% | -6,98% | -0,8% | -2,02% | -0,74% | 1,3% | 2,09% |
| Nettomarge (%) | -1,73% | -7% | -6,45% | -0,67% | -1,92% | -0,74% | 0,88% | 1,62% |
| FCF-marge (%) | -3,67% | -2,97% | -6,86% | 1,29% | -0,84% | -0,9% | 0,77% | 1,51% |
| Vrije kasstroom/nettoresultaat (%) | 211,87% | 42,49% | 106,43% | -192,97% | 44,05% | 121,03% | 87,35% | 93,1% |
Winstgevendheid | ||||||||
| ROA | -3,5% | -11,24% | -10,27% | -1,38% | -4,49% | -3,1% | 3,89% | 8,82% |
| ROE | -5,1% | -17,65% | -20,17% | -2,75% | -9,04% | -4,35% | 5,73% | 12,87% |
Financiële gezondheid | ||||||||
| Hefboom (schuld/ebitda) | - | - | -23,42x | 3x | 4,52x | 2,57x | 1,3x | 0,87x |
| Schuld/vrije kasstroom | - | - | -2,28x | 6,92x | -7,51x | -6,06x | 5,54x | 2,24x |
Kapitaalintensiteit | ||||||||
| Kapitaaluitgaven/omzet (%) | 5,51% | 4,07% | 4,44% | 2,12% | 1,78% | 2,02% | 1,99% | 1,85% |
| CAPEX / EBITDA (%) | 246,69% | -863,18% | -665,39% | 71,45% | 126,56% | 95,29% | 60,54% | 47,58% |
| CAPEX / FCF (%) | -150,1% | -136,91% | -64,77% | 164,5% | -210,49% | -224,67% | 257,61% | 122% |
Bestanddelen per aandeel | ||||||||
| Kasstroom per aandeel 1 | 1,24 | 0,6506 | -1,619 | 3,194 | 1,103 | 2,683 | 5,222 | 8,295 |
| Variatie | - | -47,53% | -348,8% | 297,34% | -65,46% | 143,18% | 94,62% | 58,85% |
| Dividend per aandeel 1 | - | - | - | - | - | - | - | - |
| Variatie | - | - | - | - | - | - | - | - |
| Nettoactief per aandeel 1 | 21,46 | 22,96 | 19,49 | 25,85 | 23,79 | 24,1 | 25,54 | 29,74 |
| Variatie | - | 6,98% | -15,12% | 32,64% | -7,95% | 1,28% | 6,01% | 16,44% |
| WPA 1 | -1,17 | -4,15 | -4,32 | -0,73 | -2,27 | -1,104 | 1,601 | 3,494 |
| Variatie | - | -254,7% | -4,1% | 83,1% | -210,96% | 51,35% | 244,97% | 118,28% |
| Aantal aandelen (in duizend) | 17.935 | 18.095 | 18.095 | 18.199 | 20.342 | 20.578 | 20.578 | 20.578 |
| Datum van publicatie | 3/03/21 | 2/03/22 | 7/03/23 | 5/03/24 | 11/03/25 | - | - | - |
1EUR
Geschatte gegevens
| 2025 * | 2026 * | |
|---|---|---|
| k/w-verhouding | -112x | 77x |
| PBR-ratio | 5,11x | 4,82x |
| EV/omzet | 0,9x | 0,74x |
| Dividendrendement | - | - |
Meer waarderingsratio's
* Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Verkoop
Koop
Gemiddeld advies
Kopen
Aantal analisten
11
Laatste slotkoers
124,80EUR
Gemiddelde koersdoel
169,36EUR
Spread / Gemiddelde doel
+35,71%
